Xcout Intel
Cellares
Cellares Corp is a for-profit biopharmaceutical company that provides global biopharmaceutical services and operates out of South San Francisco.
Subscribe to see Cellares’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cellares at a glance
Cellares is a biotech company headquartered in United States. Its most recent funding round, Series D, raised $418.6M in June 2026. Xcout tracks 1 named person at Cellares, including Fabian Gerlinghaus (co-founder and CEO). Xcout recorded 1 job posting from Cellares in the last 90 days.
Cellares leadership
- Fabian Gerlinghausco-founder and CEO
Cellares funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $418.6M | 15 named | |
| Series D | $257M | 12 named | |
| Series D | $327M | 13 named | |
| — | $82M | 13 named | |
| — | $18M | 13 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Cellares
Xcout recorded 1 job posting from Cellares in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Cellares's hiring signals →
Recent Cellares news
Investors
Tech stack
Cellares competitors
A few of Cellares's closest competitors — see the full list of competitors and alternatives →
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Selexis SA is a Swiss biotechnology company that develops mammalian cell-line development technologies and provides cell-line engineering and development services for biopharmaceutical companies. Its platforms support the production of therapeutic proteins and biologics, serving drug developers and manufacturers.
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
GeneFab is a cell and gene therapy CDMO founded in 2023, headquartered in Alameda, California, making advanced therapies accessible through specialized partnerships.
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO) headquartered in Durham, North Carolina. The company specializes in cell line development, analytical testing, and process manufacturing services for biopharmaceutical clients worldwide.
Resilience Therapeutics, Inc. operates as a biomanufacturing contract development and manufacturing organization (CDMO) that provides drug substance and drug product manufacturing services for biologics and cell therapies. The company serves biopharmaceutical clients by offering end-to-end development, scale-up, fill/finish, and supply chain solutions to help commercialize complex medicines.
Get Cellares's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Cellares? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cellares in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access